We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$34M |
| 2 |
ExxonMobil
XOM
|
+$33.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 4 |
3M
MMM
|
+$32.4M |
| 5 |
McDonald's
MCD
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70M |
| 2 |
W.R. Berkley
WRB
|
+$12.8M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
+$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
+$11.2M |
| 5 |
Gen Digital
GEN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Allogene Therapeutics
ALLO
$601M
| $853K | ﹤0.01% |
+32,842
| New | +$905K |
|
|
DCPH
852
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $853K | ﹤0.01% |
13,703
-1,729
| -11% | -$82.2K |
|
853
Brighthouse Financial
BHF
$3.63B
| $851K | ﹤0.01% |
21,702
+180
| +0.8% | +$7.08K |
|
854
Mercury Systems
MRCY
$6.2B
| $851K | ﹤0.01% |
12,310
+4,492
| +57% | +$324K |
|
|
DHC
855
Diversified Healthcare Trust
DHC
$2.26B
| $846K | ﹤0.01% |
100,184
+5,544
| +6% | +$46.7K |
|
856
LPL Financial
LPLA
$26.3B
| $845K | ﹤0.01% |
9,161
-494
| -5% | -$42.4K |
|
857
The GEO Group
GEO
$4.13B
| $844K | ﹤0.01% |
50,838
+2,773
| +6% | +$42.1K |
|
|
STL
858
DELISTED
Sterling Bancorp
STL
| $844K | ﹤0.01% |
40,015
+515
| +1% | +$10.5K |
|
|
MASI
859
DELISTED
Masimo
MASI
| $842K | ﹤0.01% |
5,329
+485
| +10% | +$72.9K |
|
860
Texas Roadhouse
TXRH
$12.7B
| $832K | ﹤0.01% |
14,776
+2,055
| +16% | +$113K |
|
861
CACI
CACI
$10.8B
| $831K | ﹤0.01% |
3,324
+274
| +9% | +$63.8K |
|
862
Affiliated Managers Group
AMG
$9.46B
| $827K | ﹤0.01% |
9,762
-2,336
| -19% | -$192K |
|
|
EFOR
863
Everforth Inc
EFOR
$845M
| $826K | ﹤0.01% |
11,640
+1,616
| +16% | +$105K |
|
|
ARQL
864
DELISTED
Arqule Inc
ARQL
| $825K | ﹤0.01% |
41,316
-4,096
| -9% | -$47.5K |
|
|
HRC
865
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $824K | ﹤0.01% |
7,261
+655
| +10% | +$69K |
|
866
FNB Corp
FNB
$6.78B
| $818K | ﹤0.01% |
64,387
+1,807
| +3% | +$22.2K |
|
867
Acadia Realty Trust
AKR
$2.99B
| $816K | ﹤0.01% |
31,461
+2,214
| +8% | +$60.6K |
|
|
TGNA
868
DELISTED
TEGNA Inc
TGNA
| $816K | ﹤0.01% |
48,908
+6,834
| +16% | +$106K |
|
869
International Bancshares
IBOC
$4.77B
| $814K | ﹤0.01% |
18,895
+1,449
| +8% | +$60.1K |
|
870
Charles River Laboratories
CRL
$10.9B
| $811K | ﹤0.01% |
5,312
+487
| +10% | +$67.4K |
|
871
Diamondrock Hospitality Co
DRH
$2.63B
| $810K | ﹤0.01% |
73,112
+3,215
| +5% | +$33.2K |
|
872
WEX
WEX
$6.11B
| $810K | ﹤0.01% |
3,868
+425
| +12% | +$85.2K |
|
873
Kodiak Sciences
KOD
$2.59B
| $807K | ﹤0.01% |
+11,210
| New | +$408K |
|
874
Myriad Genetics
MYGN
$530M
| $805K | ﹤0.01% |
29,551
-2,040
| -6% | -$56.1K |
|
|
EQC
875
DELISTED
Equity Commonwealth
EQC
| $805K | ﹤0.01% |
24,527
-966
| -4% | -$31.1K |
|
Similar funds
ProShare Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.
- ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
- ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
- ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
- ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
- ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
- ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
- ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.